Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) from a buy rating to a hold rating in a research report report published on Friday morning. A number of other research analysts also recently commented on KNSA. Citigroup started coverage on Kiniksa Pharmaceuticals in a research note on Thursday, March 13th. They […]
Wall Street Zen downgraded shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) from a buy rating to a hold rating in a research report report published on Friday morning. A number of other research analysts also recently commented on KNSA. Citigroup started coverage on Kiniksa Pharmaceuticals in a research note on Thursday, March 13th. They […]
